
LYRA
Healthcare · Biotechnology · $337,227 market cap
$0.19000.00 (0.0%)Nov 13, 9:30 AM EST
Latest report
After the close
The next earnings date isn’t on the calendar yet.
Analyst consensus
Fiscal period ending Dec 31, 2025
EPS trend, 90 days to now · -63.8% over 90 days · 30-day revisions 1 up, 0 down
Beat estimates in 2 of the last 4 reported quarters.
EPS surprise versus the estimate at the time of the report.
| Date | Session | Estimate | Actual | Surprise |
|---|---|---|---|---|
| Nov 12, 2025 | After the close | -4.07 | -3.40 | +16.5% |
| Aug 12, 2025 | After the close | -4.78 | -5.22 | -9.2% |
| May 6, 2025 | After the close | -6.83 | -6.50 | +4.8% |
| Mar 19, 2025 | Before the open | -0.13 | -0.14 | -9.2% |
| Nov 12, 2024 | After the close | -10.25 | -6.92 | +32.5% |
| Aug 14, 2024 | After the close | -16.40 | -12.95 | +21.0% |
| Apr 30, 2024 | After the close | -13.40 | -17.50 | -30.6% |
| Mar 21, 2024 | After the close | -0.31 | -0.22 | +29.0% |
| Nov 7, 2023 | After the close | -14.75 | -13.50 | +8.5% |
| Aug 8, 2023 | After the close | -21.50 | -16.05 | +25.3% |
| May 12, 2023 | Before the open | -0.36 | -0.44 | -22.2% |
| Mar 29, 2023 | After the close | -20.87 | -15.75 | +24.5% |
| Nov 8, 2022 | After the close | -22.37 |
Lyra Therapeutics, Inc., a clinical-stage biotechnology company, focuses on the development and commercialization of anti-inflammatory therapies for the treatment of patients with chronic rhinosinusitis. Its technology is designed to deliver medicines directly to the affected tissue for sustained periods with a single administration. The company's product candidates include LYR-210, an anti-inflammatory implantable…
| -20.00 |
| +10.6% |
| Aug 9, 2022 | Before the open | -17.00 | -21.50 | -26.5% |
| May 10, 2022 | Before the open | -0.91 | -0.54 | +40.7% |
| Mar 9, 2022 | Before the open | -39.50 | -52.50 | -32.9% |
| Nov 9, 2021 | After the close | -36.75 | -42.50 | -15.6% |
| Aug 9, 2021 | After the close | -33.50 | -42.50 | -26.9% |
| May 11, 2021 | After the close | -26.50 | -30.00 | -13.2% |
| Mar 9, 2021 | After the close | -0.56 | -0.46 | +17.9% |
| Nov 10, 2020 | After the close | -20.50 | -24.50 | -19.5% |
| Aug 5, 2020 | After the close | -17.50 | -28.00 | -60.0% |
| May 28, 2020 | After the close | -0.49 | -18.70 | -3716.3% |
| Mar 6, 2020 | Time not confirmed | — | -1.32 | — |